Soluble urokinase plasminogen activator receptor (suPAR) is a signaling glycoprotein implicated in the pathogenesis of kidney disease [38] previously associated in sepsis and COVID-19 with an increased risk of AKI and mortality [19, 20, 39–42]. This evidence concerns the gene PLAUR and COVID-19.